Involvement of SIRT1-mediated aging in liver diseases
Frontiers in Cell and Developmental Biology · 20.02.2025 · 13
DOI: 10.3389/fcell.2025.1548015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 20.02.2025. Verfasst von Yueming Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liver disease is a significant global health issue, responsible for millions of deaths annually. Aging, characterized by the gradual decline in cellular and physiological functions, impairs tissue regeneration, increases susceptibility to liver diseases, and leads to a decline in liver health. Silent information regulator 1 (SIRT1), a NAD⁺-dependent deacetylase, has emerged as a pivotal factor in modulating age-related changes in the liver. SIRT1 preserves liver function by regulating essential aging-related pathways, including telomere maintenance, epigenetic modifications, cellular senescence, intercellular communication, inflammation, and mitochondrial function. Notably, SIRT1 levels naturally decline with age, contributing to liver disease progression and increased vulnerability to injury. This review summarizes the regulatory role of SIRT1 in aging and its impact on liver diseases such as liver fibrosis, alcoholic associated liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD), and metabolic dysfunction-associated steatohepatitis (MASH), hepatocellular carcinoma (HCC). We also discuss emerging therapeutic approaches, including SIRT1 activators, gene therapy, and nutritional interventions, which are evaluated for their potential to restore SIRT1 function and mitigate liver disease progression. Finally, we highlight future research directions to optimize SIRT1-targeted therapies for clinical applications in age-related liver conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, The First Hospital of Jilin University, Changchun, China.
- Department of Pharmacy, The First Hospital of Jilin University, Changchun, China.
- College of Pharmacy, Jilin University, Changchun, Jilin, China.
Zitieren
APA
Zhang, Y., Gong, C., Tao, L., Zhai, J., Huang, F., & Zhang, S. (2025). Involvement of SIRT1-mediated aging in liver diseases. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1548015
Vancouver
Zhang Y, Gong C, Tao L, Zhai J, Huang F, Zhang S. Involvement of SIRT1-mediated aging in liver diseases. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1548015
BibTeX
@article{Zhang2025,
author = {Zhang, Yueming and Gong, Chang and Tao, Lina and Zhai, Jinghui and Huang, Fengwei and Zhang, Sixi},
title = {Involvement of SIRT1-mediated aging in liver diseases},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1548015}
}
EUVIMED